Urinary Incontinence is a medical condition which involves
involuntary loss of urine. Incontinence can be either leakage of few
drops of urine or complete emptying of the bladder. Urinary
incontinence is a common complaint worldwide and causes embarrassment
and distress. Prevalence of urinary incontinence varies based on type
of incontinence and population studies. Urinary incontinence is more
common among women than men, and women experience twice the symptoms
of urinary incontinence than men. Aged women experience urinary
incontinence more often than younger women. Factors responsible for
high prevalence of urinary incontinence in women are pregnancy,
childbirth, menopause, and structure of female urinary tract.
Incontinence occurs because of issues related to muscles and nerves
that help to release or hold the urine. The common symptoms
associated with urinary incontinence is urgency, frequency, nocturia,
dysuria, and nocturnal enuresis.
Report Overview @
https://www.transparencymarketresearch.com/urinary-incontinence-treatment-devices-market.html
The global urinary incontinence treatment device market is driven by
increase in geriatric population. The geriatric population is more
prone to the problem of micturition due to high incidence of prostate
hypertrophy where the inflamed prostate impairs bladder emptying.
This increases pressure in the bladder which can weaken bladder
muscles and result in an unstable bladder, leading to incontinence.
Rising prevalence of diseases such as Parkinson’s and multiple
sclerosis which damage the nerves that control the bladder function
is driving the urinary incontinence devices market. High incidence of
overactive bladder disorder which leads to urinary incontinence also
contributes to rising demand for urinary incontinence devices.
Advancements in technology and initiatives by key players to develop
low cost devices to meet the rising demand for urinary incontinence
treatment are propelling the global urinary incontinence treatment
devices market.
The global urinary incontinence treatment devices market has been
categorized based on type of urinary incontinence, product type,
end-user, and region. In terms of type of urinary incontinence, the
market has been segmented into stress incontinence (urine leaks when
pressure is experienced by bladder during exercise, coughing,
sneezing, or lifting heavy objects), urge incontinence (leakage of
large amount of urine at unexpected time), overflow incontinence
(unexpected leakage of urine due to full bladder), and mixed
incontinence (usually due to stress and urge incontinence together).
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26612
Stress incontinence is the most common type of urinary incontinence
due to large population suffering from stress incontinence. It is
more common among women due to physical changes occurring as a result
of pregnancy, childbirth, and menopause which often result into
stress incontinence. Urge incontinence is second most common type of
urinary incontinence due to high prevalence of neurological diseases.
Based on product type, the market has been segmented into pessary,
tampons, occlusive devices, electrical stimulation devices, Foley
catheters, urethral bulking agents, and others. In terms of end-user,
the market has been segmented into hospitals, ambulatory surgical
centers, specialty clinics, and others.
Geographically, the global urinary incontinence treatment devices
market has been segmented into North America, Europe, Asia Pacific,
Latin America, and Middle East & Africa. North America accounts
for the largest share of the urinary incontinence treatment devices
market. Rising prevalence of urinary incontinence, increase in
geriatric population, growing awareness about symptoms and diagnosis
of urinary incontinence, high health care expenditure, and favorable
reimbursement scenario are factors attributed to the growth of the
urinary incontinence treatment devices market in North America.
Europe and Asia Pacific represent fast-growing markets due to rising
geriatric population, high prevalence of neurological diseases, high
incidence of stress related disorders, and increase in urinary
incontinence patient population.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=26612<ype=S
Key players in the global urinary incontinence treatment devices
market are Promedon, C. R. Bard Inc., Boston Scientific Corporation,
Ethicon US, LLC., Cook Medical, Inc., Precision Medical Devices,
Johnson & Johnson, NeoTract, Inc., American Medical Solutions,
and Coloplast Corp., among others.
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment